American International Group’s Ariad Pharmaceuticals Inc ARIA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-101,756
| Closed | -$1.27M | – | 3048 |
|
|
2016
Q4 | $1.27M | Sell |
101,756
-262
| -0.3% | -$3.15K | ﹤0.01% | 1109 |
|
|
2016
Q3 | $1.4M | Buy |
102,018
+156
| +0.2% | +$1.57K | 0.01% | 1044 |
|
|
2016
Q2 | $753K | Buy |
101,862
+3,803
| +4% | +$28.5K | ﹤0.01% | 1349 |
|
|
2016
Q1 | $627K | Hold |
98,059
| – | – | ﹤0.01% | 1828 |
|
|
2015
Q4 | $613K | Sell |
98,059
-1,156
| -1% | -$7.59K | ﹤0.01% | 1872 |
|
|
2015
Q3 | $580K | Sell |
99,215
-1,494
| -1% | -$11.5K | ﹤0.01% | 1876 |
|
|
2015
Q2 | $833K | Sell |
100,709
-5,948
| -6% | -$52.6K | ﹤0.01% | 1730 |
|
|
2015
Q1 | $879K | Sell |
106,657
-1,133
| -1% | -$8.38K | ﹤0.01% | 1714 |
|
|
2014
Q4 | $741K | Sell |
107,790
-1,880
| -2% | -$11.8K | ﹤0.01% | 1802 |
|
|
2014
Q3 | $592K | Sell |
109,670
-1,330
| -1% | -$7.77K | ﹤0.01% | 1973 |
|
|
2014
Q2 | $707K | Buy |
111,000
+49,126
| +79% | +$338K | ﹤0.01% | 1878 |
|
|
2014
Q1 | $499K | Buy |
61,874
+44,419
| +254% | +$346K | ﹤0.01% | 2091 |
|
|
2013
Q4 | $119K | Buy |
17,455
+10,035
| +135% | +$54.2K | ﹤0.01% | 3218 |
|
|
2013
Q3 | $137K | Buy |
7,420
+4,137
| +126% | +$80.3K | ﹤0.01% | 3069 |
|
|
2013
Q2 | $57.4K | Buy |
+3,283
| New | +$58.2K | ﹤0.01% | 3515 |
|
Other funds holding ARIA
American International Group's ARIA Position: Q1 2017 in Review
American International Group sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 101,756 shares — an estimated $1.27M sold.
American International Group first reported a position in ARIA in Q2 2013 and held it in 15 quarters. The position peaked at $1.4M in Q3 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.
- American International Group reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
- American International Group sold 101,756 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $1.27M.
- American International Group first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 15 quarters.
- American International Group's Ariad Pharmaceuticals Inc position peaked at $1.4M in Q3 2016.
- 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.
Based on American International Group's 13F filing for Q1 2017, filed 10 May 2017.